Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001308107 | SCV001497543 | pathogenic | Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome | 2025-01-12 | criteria provided, single submitter | clinical testing | This variant, c.128_130del, results in the deletion of 1 amino acid(s) of the TRNT1 protein (p.Glu43del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs765128768, gnomAD 0.006%). This variant has been observed in individual(s) with clinical features of TRNT1-related disorders (PMID: 26494905, 28390992; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.126_128delAGA. ClinVar contains an entry for this variant (Variation ID: 234932). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV004591043 | SCV005080627 | pathogenic | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36819107, 26494905) |
Mayo Clinic Laboratories, |
RCV004591043 | SCV005409126 | uncertain significance | not provided | 2023-11-09 | criteria provided, single submitter | clinical testing | PM4 |
OMIM | RCV000223678 | SCV000280021 | pathogenic | Retinitis pigmentosa and erythrocytic microcytosis | 2016-05-26 | no assertion criteria provided | literature only |